Call for Papers

Peer-Reviewed  ·  Open Access  ·  International

Nigerian Journal of Oncology

A Global Platform for Oncology Research and Practice

Submit Your Research Join as Reviewer
42 Articles Published
11,338 Total Views
6,261 Downloads
180 Researchers
Memberships & Indexing
Saypeace Solutions Crossref DOI Google Scholar
About Us
The Nigerian Journal of Oncology is a biannual peer reviewed open access international journal published on behalf of the Association of Radiation and Clinical Oncologist of Nigeria. The journal publishes research works related to all fields of oncology, from cancer screening to treatment and survivorship. The journal will feature original research, reviews, clinical trials, practice guidelines, editorials, case studies, scientific letters and conference reports.
Editor-in-Chief: Dr. Jimeta-Tuko Jummai Desiree

Top 10 Authors

SS
Shehu Salihu Umar 1
Department of Radiology, Ahmadu Bello Un...
SS
Shehu Salihu Umar 1
Institution
Department of Radiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria
Email
shehuumar125@gmail.com
14 Publications
3,654 Views
2,154 Downloads
3,654 2,154
SA
Sunday A. Adewuyi 2
Department of Radiation and Clinical Onc...
SA
Sunday A. Adewuyi 2
Institution
Department of Radiation and Clinical Oncology, Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
Email
sadewuyi2003@yahoo.com
6 Publications
1,503 Views
961 Downloads
1,503 961
AA
Adeniyi Adenipekun 3
University College Hospital Ibadan
AA
Adeniyi Adenipekun 3
Prof.
Institution
University College Hospital Ibadan
Email
adenipek20000@gmail.com
Phone
+2348033583256
5 Publications
1,446 Views
730 Downloads
1,446 730
FO
Foluke O. Sarimiye
Department of Radiation Oncology, Univer...
FO
Foluke O. Sarimiye
Institution
Department of Radiation Oncology, University of Ibadan/University College Hospital (UCH), Ibadan, Oyo State, Nigeria
Email
wayadoc@yahoo.com
Phone
+2348034895446
5 Publications
1,387 Views
735 Downloads
1,387 735
OT
Oiza Tessy Ahmadu
Department of Radiotherapy and Oncology,...
OT
Oiza Tessy Ahmadu
Institution
Department of Radiotherapy and Oncology, Federal Medical Centre, Abuja, FCT, Nigeria
Email
tessyoiza@yahoo.com
5 Publications
1,342 Views
758 Downloads
1,342 758
FI
Fatima Inno Uba
Department of Radiotherapy, National Hos...
FI
Fatima Inno Uba
Institution
Department of Radiotherapy, National Hospital, Abuja, Nigeria
Email
agbamufatima@yahoo.com
5 Publications
1,235 Views
784 Downloads
1,235 784
AA
Ali Abba Tijjani
Department of Radiology, University of M...
AA
Ali Abba Tijjani
Institution
Department of Radiology, University of Maiduguri, Maiduguri, Borno State, Nigeria; Department of Clinical Oncology, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria
Email
abbaalielfezangmail.com
5 Publications
1,211 Views
686 Downloads
1,211 686
JM
Jimoh mutiu alani
university of Ibadan
JM
Jimoh mutiu alani
Institution
university of Ibadan
Email
jimohmutiualani@yahoo.com
4 Publications
1,199 Views
617 Downloads
1,199 617
AI
Atara I Ntekim
Radiation Oncology Department, Universit...
AI
Atara I Ntekim
Institution
Radiation Oncology Department, University College Hospital, Ibadan, Oyo State, Nigeria
Email
kimata2000@hotmail.com
4 Publications
1,145 Views
584 Downloads
1,145 584
AO
Adewumi O. Alabi
Department of Radiation Biology, Radioth...
AO
Adewumi O. Alabi
Institution
Department of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos.
Email
adewumialabi@gmail.com
4 Publications
1,112 Views
595 Downloads
1,112 595

Browse Articles

Browse All Archives

Vol. 2, No. 1 (2026) Feb 2026

HEALTH-SYSTEM DETERMINANTS OF RETINOBLASTOMA OUTCOMES: A STRUCTURED AUDIT OF DIAGNOSTIC, THERAPEUTIC, AND SUPPORTIVE RESOURCES RELATIVE TO SIOP STANDARDS

Edak Ezeanosike*, Nneka Ogbu, Kene Joe-Akunne, Amarachi Okpara, Chinonye Ngwu, June Azu-Okeke

Background: Retinoblastoma is the most common intraocular malignancy of childhood and is highly curable when detected early, with survival exceeding 95% in high-income countries. In many low- and middle-income countries (LMICs), survival remains below 40% due to systemic and cultural barriers. Altho...

Vol. 2, No. 1 (2026) Feb 2026

SQUAMOUS CELL CARCINOMA OF THE SKIN ARISING FROM A LEPROMATOUS ULCER: A CASE REPORT

Charles Okwonna*, Mahmud Ahmed, Sunday A. Adewuyi, Adamu Abdullahi, Shehu Salihu Umar

Background: Non-melanoma skin cancers (NMSC) are among the most frequently diagnosed malignancies globally. While basal cell carcinoma predominates in fair-skinned populations, squamous cell carcinoma (SCC) is relatively more common among black populations. Chronic ulcers, including rare cases of le...

Vol. 2, No. 1 (2026) Feb 2026

SPIRITUALITY AND RELIGIOSITY IN ONCOLOGY: A SOCIAL STUDY OF PATIENTS’ NEEDS

Chidiebere Agbakwuru*, Jimoh mutiu alani, Noah Olumide, Anthonia Sowunmi, Wilfred Nwachukwu

Background: Cancer diagnosis and treatment impose significant psychological and existential burdens, particularly in high-religiosity settings like Nigeria, where spirituality and religion often serve as key coping resources. This study examined spiritual well-being (SWB) and its associations with p...

Vol. 2, No. 1 (2026) Feb 2026

RECURRENT RECTAL ADENOCARCINOMA WITH KRAS MUTATION POST-MFOLFOX6/BEVACIZUMAB REMISSION: A CASE REPORT

Yusuf Tukur*, Abubakar M. Bello, Usman M. Aliyu, Oladapo B. Campbell, Aisha Mustapha, Abubakar Ibrahim Diggi, Yusuf Dantani, Shehu Salihu Umar

Background: This case report elucidates the clinical trajectory of a 41-year-old male diagnosed with low rectal adenocarcinoma, further complicated by pulmonary metastases, harboring a KRAS mutation, and characterized by microsatellite stability. Case Presentation: This patient demonstrated a signif...

Vol. 2, No. 1 (2026) Feb 2026

OUTCOME OF HEAD AND NECK CANCER PATIENTS MANAGED WITH CHEMORADIATION AT THE RADIOTHERAPY DEPARTMENT NATIONAL HOSPITAL, ABUJA (A FIVE-YEAR RETROSPECTIVE STUDY)

Fatima Inno Uba*, Simeon C. Aruah, Festus Igbinoba, Rasaaq A. Oyesegun

Background: The term ‘Head and Neck Cancer’ usually refers to squamous cell carcinomas that affect the head and neck regions of the body. However, other histologies are also found in these regions. Objective: This study assessed the outcome of head and neck cancer patients managed with chemoradiatio...

Vol. 2, No. 1 (2026) Feb 2026

HPV VACCINATION IN NIGERIA: LESSONS AND RECOMMENDATIONS FROM THE SUCCESSES OF HPV VACCINATION IN THE UNITED STATES

Adeola O. Fakolade*, Abimbola Fapohunda, Amanda Yad-El Ugboji, Valentina Ijeoma Akpa, Moyosore Adegboye, Oge Ilegbune

Human Papilloma Virus (HPV) is one of the most common sexually transmitted infections (STIs) and has been implicated in many cancers, including cervical cancer. Cervical cancer is primarily caused by persistent infection of various high-risk HPV types, and HPV vaccination is a vital and cost-effecti...

Vol. 2, No. 1 (2026) Feb 2026

EVALUATION OF SCREENING MAMMOGRAPHY RESULTS IN A COHORT OF FEMALE HEALTH CARE WORKERS AT THE FEDERAL MEDICAL CENTER, ABUJA, NIGERIA

Oiza Tessy Ahmadu*, Uchechukwu E. Nwokwu, Olayinka B. Popoola, Adaugo C. Iheanacho, Lateef Lawal, Amarachi. N. Onyebuchi, Rahama Y. Tahir, Tolulope Oloyede, Saad A Ahmed

Background: Mammographic screening has significantly reduced breast cancer mortality in developed countries. However, data on screening outcomes in asymptomatic populations in Nigeria remain limited. Objective: To determine the distribution of BI-RADS categories and breast density patterns among asy...

Vol. 2, No. 1 (2026) Feb 2026

DEVELOPING CAPACITY OF PRIMARY HEALTH CENTRES IN SCREENING, EARLY DIAGNOSIS AND APPROPRIATE REFERRAL OF CERVICAL CANCER IN A LOW-RESOURCE SETTING: A PILOT INTERVENTIONAL STUDY

Shehu Salihu Umar*, Aisha Jamila Ahmad, Anisa Yahya, Mus’ab M. Dalhat, Kabiru Adamu, Khadija M. Kanoma, Zaharaddeen Shuaibu Babandi, Muazu Abdus-Salam, Benjamin O. Popoola

Background: Despite cervical cancer being preventable and treatable if detected early, it is predominantly characterised by late presentation with advanced disease in low-resource settings. This is due to a poor level of awareness of cervical cancer in the population. The Primary Health Centres (PHC...

Vol. 2, No. 1 (2026) Feb 2026

COMPARATIVE OUTCOMES OF RADIATION TREATMENT MODALITIES FOR PROSTATE CANCER IN A RESOURCE-LIMITED SETTING

Oladeji Afolabi adebayo, Ayorinde M. Folasire*, Foluke O. Sarimiye, Chiamaka Ehiedu, Olabisi T. Ojo

Background: Prostate cancer remains a major malignancy in sub-Saharan Africa, where access to advanced radiotherapy is limited. Objective: This study compares biochemical recurrence-free survival (bRFS) and toxicity outcomes among prostate cancer patients who received external beam radiotherapy (EBR...

Vol. 2, No. 1 (2026) Feb 2026

CLINICOPATHOLOGICAL CHARACTERISTICS OF BREAST CANCER PATIENTS WHO PRESENTED AT A SOUTHWESTERN NIGERIAN RADIATION ONCOLOGY CLINIC

Bolaji L. Salako, Abbas A Abdus-Salam, Ajibike A. Orekoya*, Adeniyi A Olabumuyi, Sharif A. Folorunso, Adeniyi Adenipekun, Atara I Ntekim, Babatunde O Ogunnorin, Oladeji Afolabi adebayo, Jimoh mutiu alani, Foluke O. Sarimiye, Ayorinde M. Folasire

Background: Breast cancer is the commonest female cancer in Nigeria and is also the commonest cause of cancer mortality among Nigerian females. Although the incidence is not as high as the average worldwide incidence rate, the mortality of breast cancer patients in Nigeria is high. Objective: We ana...

Browse all 42 articles →

Editorial Board

View Full Board
P

Prof Adewuyi Sunday

Advisory Board

Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria

D

Dr. Jimeta-Tuko Jummai Desiree

Editor In Chief

Diagnostic and Treatment Centre, Central Bank of Nigeria

Nigeria

P

Prof Jonah Musa

Advisory Board

Jos University Teaching Hospital, Plateau State, Nigeria

P

Prof Sowunmi Omowunmi

Advisory Board

NSIA-LUTH Cancer Centre Lagos State, Nigeria

Nigeria

Submit Your Research

Share your discoveries with the global research community through our rigorous peer review process.

Author Guidelines

Become a Reviewer

Join our community of expert reviewers and contribute to advancing knowledge in your field.

Register Now